PatchTheCVECVE-2026-70441: Jenkins Summary Display Plugin 1.15 and earlier does not escape the job name in a JavaScript context in build
CVE-2026-70441 is a medium-severity flaw (CVSS 5.4) affecting affected software. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Jenkins Summary Display Plugin 1.15 and earlier does not escape the job name in a JavaScript context in build report pages, resulting in a stored cross-site scripting (XSS) vulnerability exploitable by attackers with Item/Create or Item/Configure permission.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 5.4 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | Required |
| EPSS exploit chance | 0.2% (top 87%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2026-08-05 |
| Last modified | 2026-10-23 |
Last updated 2026-10-23 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2026-70441?
No fixed release is listed yet. Watch the vendor advisory and apply any mitigation shown on this page.
Is CVE-2026-70441 being exploited?
CVE-2026-70441 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2026-70441 affect?
CVE-2026-70441 affects affected software. Severity is medium (CVSS 5.4). Jenkins Summary Display Plugin 1.15 and earlier does not escape the job name in a JavaScript context in build report pages, resulting in a stored cross-site scripting (XSS) vulnerability exploitable by attackers with Item/Create or Item/Con
How urgent is CVE-2026-70441?
Priority 22/100. No elevated risk signals yet.